Drug Development

Listings
  • Anti-24P4C12 (clone Ha5-l(5)2.1)-VC-MMAE ADC

    Anti-24P4C12 (clone Ha5-l(5)2.1)-VC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-24P4C12 monoclonal antibody (clone Ha5-l(5)2.1)) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytos...

  • Anti-DLL3-PBD ADC

    Anti-DLL3-PBD ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody conjugated via a linker to PDB. The PDB is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, PDB bind...

  • Anti-24P4C12 proteins (clone (Ha5)-1(5)2.1)-VC-MMAE ADC

    Anti-24P4C12 proteins (clone (Ha5)-1(5)2.1)-VC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-24P4C12 proteins monoclonal antibody (clone (Ha5)-1(5)2.1) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated...

  • Anti-DLL3-PBD ADC

    Anti-DLL3-PBD ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody conjugated via a linker to PDB. The PDB is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, PDB bind...

  • Anti-CA6 (clone huDS6)-SPDB-DM4 ADC

    Anti-CA6 (clone huDS6)-SPDB-DM4 ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an Anti-MUC1 antibody (clone huDS6) conjugated via a SPDB linker to DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, ...

  • Anti-EDA (clone F8)-SS-DM1 ADC

    Anti-EDA (clone F8)-SS-DM1 ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-EDA monoclonal antibody (clone F8) conjugated via a linker to a DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the ce...

  • Anti-CA9-MCC-MMAE ADC

    Anti-CA9-MCC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CA9 monoclonal antibody conjugated via a MCC linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, M...

  • Anti-EDNRB (endothelin B)-VC-MMAE ADC

    Anti-EDNRB (endothelin B)-VC-MMAE ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-EDNRB monoclonal antibody conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MM...

  • Anti-CA9-VC-MMAE ADC

    Anti-CA9-VC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CA9 monoclonal antibody conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE...

  • Anti-EDNRB-VC-MMAE ADC

    Anti-EDNRB-VC-MMAE ADC

    Drug Development Shirleyc (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-EDNRB monoclonal antibody conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MM...

  • Anti-CD180 (MHR73-11)-SPP-DM1 ADC

    Anti-CD180 (MHR73-11)-SPP-DM1 ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD180 monoclonal antibody ( MHR73-11) conjugated via a SPP linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within t...

  • Anti-EDNBR (clone 5E9)-VC-MMAE ADC

    Anti-EDNBR (clone 5E9)-VC-MMAE ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-EDNRB monoclonal antibody (clone 5E9) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within ...